Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
NVALT Study Group, Christi M J Steendam, Robert Peric, Nico C van Walree, Magdolen Youssef, Franz M N H Schramel, Pepijn Brocken, John W G van Putten, Vincent van der Noort, G D Marijn Veerman, Stijn L W Koolen, Harry J M Groen, Anne-Marie C Dingemans, Ron H J Mathijssen, Egbert F Smit, Joachim G J V Aerts*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
1Citation
(Scopus)
40Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma'. Together they form a unique fingerprint.